Coronavirus Vaccine Trials
-
{
- All
- News
-
Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume
The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Russia To Begin Coronavirus Vaccine Trials On Humans In June
The head of a top Russian research centre told President Vladimir Putin on Tuesday that his lab was ready to start human trials of experimental coronavirus vaccines in June.
-
Johnson & Johnson Pauses Covid Vaccine Trial As Participant Falls Ill
Johnson & Johnson said Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants had become sick.
-
Ready To Restart: Indian Drug Firm After UK Covid Vaccine Trials Resume
The Serum Institute of India (SII) is ready to restart coronavirus vaccine trials - pending permission from the Drug Controller General of India (DGCI) - the manufacturer said in a statement on Saturday evening
-
US Pharma Firm Moderna's COVID-19 Vaccine Candidate Enters Late-Stage Trial
Moderna said on Monday it has started a US government-backed late-stage trial to assess its COVID-19 vaccine candidate in about 30,000 adults who do not have the respiratory illness caused by the new coronavirus.
-
Man Receives First Dose Of Covaxin In Phase-I Of Human Trial At Delhi AIIMS
The phase-I human clinical trial of India's first indigenously-developed vaccine against novel coronavirus, Covaxin, began at Delhi AIIMS on Friday and the first dose of the injection was administered to a man who is in his 30s.
-
Russia To Begin Coronavirus Vaccine Trials On Humans In June
The head of a top Russian research centre told President Vladimir Putin on Tuesday that his lab was ready to start human trials of experimental coronavirus vaccines in June.
